Pupillenfunktionsstörung, Anisokorie und Irisdepigmentierung im Anschluss an COVID-19

• Literatur

• 1 Chwalisz BK, Dinkin MJ. Disease of the Year: COVID-19 and Its Neuro-ophthalmic Complications. J Neuroophthalmol 2020; 40: 283-284
• 2 Gopal M, Ambika S, Padmalakshmi K. Tonic Pupil Following COVID-19. J Neuroophthalmol 2021; 41: e764-e766
• 3 Thompson HS. Adieʼs syndrome: some new observations. Trans Am Ophthalmol Soc 1977; 75: 587-626
• 4 De Smit E, OʼSullivan E, Mackey DA. et al. Giant cell arteritis: ophthalmic manifestations of a systemic disease. Graefes Arch Clin Exp Ophthalmol 2016; 254: 2291-2306
• 5 Altan C, Basarir B, Bayraktar S. et al. Bilateral Acute Depigmentation of Iris (BADI) and Bilateral Acute Iris Transillumination (BAIT) Following Acute COVID-19 Infection. Ocul Immunol Inflamm 2022;
• 6 Thompson HS, Zackon DH, Czarnecki JS. Tadpole-shaped pupils caused by segmental spasm of the iris dilator muscle. Am J Ophthalmol 1983; 96: 467-477
• 7 Zeppieri M. Pigment dispersion syndrome: A brief overview. J Clin Transl Res 2022; 8: 344-350
• 8 Wu P, Duan F, Luo C. et al. Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol 2020; 138: 575-578
• 9 Yagci BA, Atas F, Kaya M. et al. COVID-19 Associated Bilateral Acute Iris Transillumination. Ocul Immunol Inflamm 2021; 29: 719-721
• 10 Gaur S, Sindhu N, Singh DV. et al. COVID-19-related bilateral acute de-pigmentation of iris with ocular hypertension. Indian J Ophthalmol 2022; 70: 3136-3139
• 11 Öztürk Y, Yıldız MB, Bolaç R. Evaluation of Pupillometric Parameters in Patients with COVID-19. Ocul Immunol Inflamm 2023; 31: 39-43